November 15-16, 2027  | Hilton Arlington National Landing, Arlington, VA USA

Naomi Schwartz

Vice President, Regulatory Strategy, MedCrypt

Naomi Schwartz

Vice President, Regulatory Strategy, MedCrypt

Biography

Naomi is the Vice President of Services at Medcrypt, a medical device cybersecurity firm. She leads a team of cybersecurity subject matter experts who help medical device manufacturers design appropriate security into their devices, perform threat modeling and cybersecurity risk analyses, and ensure that submission documentation is complete and ready for regulators including FDA, HealthCanada, MDR/IVDR in EU, and others worldwide. Medcrypt has created a SaaS tool, Helm that helps medical device manufacturers manage their software supply chain for products by creating or ingesting software bills of material (SBOM), identifying completeness gaps vis-a-vis NIST SBOM requirements, and evaluating the components used for cybersecurity vulnerabilities from the Common Vulnerabilities and Exposures (CVE) databases and known exploited vulnerabilities (KEVs) from various databases. The software supply chain management activities that are supported by Helm are required elements for FDA and EU notified bodies, as well as supporting submissions worldwide.

Naomi was a premarket reviewer and consumer safety officer in FDA’s Center for Devices and Radiological Health (CDRH) for 6.5 years focused on software, interoperability, cybersecurity and wireless coexistence for connected diabetes devices. While at FDA, Naomi helped craft standards including IEEE P2621.1-.3: standards and recommended practice for wireless diabetes device security assurance evaluation, security requirements and use of mobile devices in control contexts; and managed postmarket triage for cybersecurity vulnerability disclosure in diabetes devices and IVDs.

Prior to that, Naomi was a defense contractor (for 15 years) developing radar systems for the US DoD.

All sessions by Naomi Schwartz